{"schema_version":"1","generated_at":"2026-11-03T23:27:17.513Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nathan-krah","json_url":"https://www.findmykol.com/kol/nathan-krah/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nathan-krah","name":"Nathan Krah","credential":"MD, PhD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Utah","institution_url":"https://www.findmykol.com/institution/huntsman-cancer-institute-university-of-utah","city":"Salt Lake City","state":"UT","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1588292585","orcid":"0009-0003-8297-7359","openalex":"A5005193747"},"summary":"Nathan Krah is an Oncology physician affiliated with University of Utah. OpenAlex indexes 61 publications with 3,005 citations (h-index 18).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":61,"cited_by_count":3005,"h_index":18,"latest_activity_year":2026,"emerging":true,"source":"works"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cardiovascular","share_pct":100,"classes_total":2,"classes":[{"class":"Statin","setting":"prescribed","share_pct":53.8,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":null},{"class":"ACE inhibitor","setting":"prescribed","share_pct":46.2,"drugs":[{"name":"Lisinopril","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":2015,"last":2026},"rows_total":7,"shown":3,"withheld":4,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"F32HL177926","title":"The impact of pyruvate metabolic fate in myofibroblast differentiation in myelofibrosis.","fiscal_year":2026,"amount_usd":"84148","organization":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","source_url":"https://reporter.nih.gov/quickSearch/F32HL177926"},{"project":"F32HL177926","title":"The impact of pyruvate metabolic fate in myofibroblast differentiation in myelofibrosis.","fiscal_year":2025,"amount_usd":"80224","organization":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","source_url":"https://reporter.nih.gov/quickSearch/F32HL177926"},{"project":"F30CA192819","title":"A differentiation-based mechanism limiting pancreatic tumor initiation","fiscal_year":2019,"amount_usd":"50016","organization":"UNIVERSITY OF UTAH","source_url":"https://reporter.nih.gov/quickSearch/F30CA192819"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"RNA-triggered cell killing with CRISPR–Cas12a2","year":2026,"journal":"Nature","source_url":"https://doi.org/10.1038/s41586-026-10466-y","status":"verified"},{"title":"Targeting cancer-specific mutations with RNA-triggered chromatin shredding","year":2026,"journal":"Nature","source_url":"https://doi.org/10.1038/s41586-026-10738-7","status":"verified"},{"title":"SLC16A6 is a tyrosine transporter for the melanosome","year":2026,"journal":"bioRxiv (Cold Spring Harbor Laboratory)","source_url":"https://doi.org/10.64898/2026.07.06.736842","status":"verified"},{"title":"Abstract 7157: Programmable RNA-triggered cancer cell elimination using CRISPR-Cas12a2","year":2026,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2026-7157","status":"verified"},{"title":"Selective Elimination of TP53 Mutant Cells by Transcript-Activated Chromatin Shredding","year":2026,"journal":"bioRxiv (Cold Spring Harbor Laboratory)","source_url":"https://doi.org/10.64898/2026.05.08.723607","status":"verified"}],"source":"works"},"similar":[{"name":"Howard Colman","slug":"howard-colman","institution":"University of Utah","specialty":"Neurology","url":"https://www.findmykol.com/kol/howard-colman","json_url":"https://www.findmykol.com/kol/howard-colman/profile.json"},{"name":"Mark Rapaport","slug":"mark-rapaport","institution":"University of Utah","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/mark-rapaport","json_url":"https://www.findmykol.com/kol/mark-rapaport/profile.json"},{"name":"Daniel Clegg","slug":"daniel-clegg","institution":"University of Utah","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/daniel-clegg","json_url":"https://www.findmykol.com/kol/daniel-clegg/profile.json"},{"name":"Dennis Shrieve","slug":"dennis-shrieve","institution":"University of Utah","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/dennis-shrieve","json_url":"https://www.findmykol.com/kol/dennis-shrieve/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":4,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}